Published in J Virol on November 01, 1984
Neutralizing monoclonal antibodies specific for herpes simplex virus glycoprotein D inhibit virus penetration. J Virol (1987) 3.74
Localization of epitopes of herpes simplex virus type 1 glycoprotein D. J Virol (1985) 2.71
Fine mapping of antigenic site II of herpes simplex virus glycoprotein D. J Virol (1989) 2.68
Potent neutralizing activity associated with anti-glycoprotein D specificity among monoclonal antibodies selected for binding to herpes simplex virions. J Virol (1985) 2.42
Monoclonal antibodies to distinct sites on herpes simplex virus (HSV) glycoprotein D block HSV binding to HVEM. J Virol (1998) 2.11
Identification of functional regions of herpes simplex virus glycoprotein gD by using linker-insertion mutagenesis. J Virol (1994) 1.85
A synthetic peptide induces long-term protection from lethal infection with herpes simplex virus 2. J Exp Med (1987) 1.78
Antigenic analysis of a major neutralization site of herpes simplex virus glycoprotein D, using deletion mutants and monoclonal antibody-resistant mutants. J Virol (1988) 1.74
Functional region IV of glycoprotein D from herpes simplex virus modulates glycoprotein binding to the herpesvirus entry mediator. J Virol (1998) 1.70
The major neutralizing antigenic site on herpes simplex virus glycoprotein D overlaps a receptor-binding domain. J Virol (1999) 1.57
Synthetic glycoprotein D-related peptides protect mice against herpes simplex virus challenge. J Virol (1985) 1.51
Antigenic variation (mar mutations) in herpes simplex virus glycoprotein B can induce temperature-dependent alterations in gB processing and virus production. J Virol (1986) 1.39
Identification of a site on herpes simplex virus type 1 glycoprotein D that is essential for infectivity. J Virol (1990) 1.26
Human T-lymphocyte response in vitro to synthetic peptides of herpes simplex virus glycoprotein D. Proc Natl Acad Sci U S A (1985) 1.12
A computer graphics program system for protein structure representation. Nucleic Acids Res (1988) 1.07
Peptide immunogen mimicry of putative E1 glycoprotein-specific epitopes in hepatitis C virus. J Virol (1994) 1.07
Use of synthetic peptides to map the antigenic determinants of glycoprotein D of herpes simplex virus. J Virol (1988) 1.03
Antibodies against synthetic peptides of herpes simplex virus type 1 glycoprotein D and their capability to neutralize viral infectivity in vitro. J Virol (1988) 0.93
Analysis of the role of antibody-dependent cellular cytotoxic antibody activity in murine neonatal herpes simplex virus infection with antibodies to synthetic peptides of glycoprotein D and monoclonal antibodies to glycoprotein B. J Clin Invest (1990) 0.92
Polymeric display of immunogenic epitopes from herpes simplex virus and transmissible gastroenteritis virus surface proteins on an enteroadherent fimbria. Clin Diagn Lab Immunol (1999) 0.80
Competitive inhibition by human sera of mouse monoclonal antibody binding to glycoproteins C and D of herpes simplex virus types 1 and 2. J Virol (1985) 0.77
Antibody to HSV gD peptide induced by vaccination does not protect against HSV-2 infection in HSV-2 seronegative women. PLoS One (2017) 0.76
Prediction of protein antigenic determinants from amino acid sequences. Proc Natl Acad Sci U S A (1981) 32.98
Prediction of protein conformation. Biochemistry (1974) 20.51
Conformational parameters for amino acids in helical, beta-sheet, and random coil regions calculated from proteins. Biochemistry (1974) 12.07
Monoclonal antibodies to herpes simplex virus type 1 proteins, including the immediate-early protein ICP 4. Infect Immun (1981) 7.17
Type-common CP-1 antigen of herpes simplex virus is associated with a 59,000-molecular-weight envelope glycoprotein. J Virol (1978) 5.12
New procedures for preparation and isolation of conjugates of proteins and a synthetic copolymer of D-amino acids and immunochemical characterization of such conjugates. Biochemistry (1979) 5.02
Generation of protein-reactive antibodies by short peptides is an event of high frequency: implications for the structural basis of immune recognition. Proc Natl Acad Sci U S A (1983) 4.56
Herpes simplex virus type-1 glycoprotein D gene: nucleotide sequence and expression in Escherichia coli. Science (1982) 4.28
Serological analysis of herpes simplex virus types 1 and 2 with monoclonal antibodies. Infect Immun (1982) 4.22
Localization and synthesis of an antigenic determinant of herpes simplex virus glycoprotein D that stimulates the production of neutralizing antibody. J Virol (1984) 3.53
Purification of glycoprotein gD of herpes simplex virus types 1 and 2 by use of monoclonal antibody. J Virol (1982) 2.71
Comparative structural analysis of glycoprotein gD of herpes simplex virus types 1 and 2. J Virol (1980) 2.65
Effect of monoclonal antibodies on limited proteolysis of native glycoprotein gD of herpes simplex virus type 1. J Virol (1982) 2.62
Glycoproteins of herpes simplex virus type 2 as defined by monoclonal antibodies. J Virol (1982) 2.24
DNA sequence of the Herpes simplex virus type 2 glycoprotein D gene. Gene (1983) 2.05
DNA sequence analysis of the type-common glycoprotein-D genes of herpes simplex virus types 1 and 2. DNA (1984) 1.62
Enzymic and immunochemical properties of lysozyme. Evaluation of several amino group reversible blocking reagents. Biochemistry (1970) 1.37
Correlation between the conformation of cytochrome c peptides and their stimulatory activity in a T-lymphocyte proliferation assay. Proc Natl Acad Sci U S A (1983) 1.15
Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor. Science (1998) 7.89
A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell (1999) 6.82
Type-common CP-1 antigen of herpes simplex virus is associated with a 59,000-molecular-weight envelope glycoprotein. J Virol (1978) 5.12
Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus. Proc Natl Acad Sci U S A (1983) 4.54
Herpes simplex virus glycoprotein D bound to the human receptor HveA. Mol Cell (2001) 4.44
Three classes of cell surface receptors for alphaherpesvirus entry. Virology (2000) 4.41
LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator. Immunity (1998) 4.23
Phosphocholine binding immunoglobulin Fab McPC603. An X-ray diffraction study at 2.7 A. J Mol Biol (1986) 4.16
Structural analysis of the capsid polypeptides of herpes simplex virus types 1 and 2. J Virol (1980) 3.95
The three-dimensional structure of a phosphorylcholine-binding mouse immunoglobulin Fab and the nature of the antigen binding site. Proc Natl Acad Sci U S A (1974) 3.92
Glycoprotein C of herpes simplex virus 1 acts as a receptor for the C3b complement component on infected cells. Nature (1984) 3.80
Localization and synthesis of an antigenic determinant of herpes simplex virus glycoprotein D that stimulates the production of neutralizing antibody. J Virol (1984) 3.53
Interactions of protein antigens with antibodies. Proc Natl Acad Sci U S A (1996) 3.53
X-ray fiber diffraction and model-building study of polyguanylic acid and polyinosinic acid. J Mol Biol (1975) 3.50
Three-dimensional structure of an antibody-antigen complex. Proc Natl Acad Sci U S A (1987) 3.48
Differentiation of T cells induced by preparations from thymus and by nonthymic agents. J Exp Med (1973) 3.12
Isolation of a herpes simplex virus-specific antigenic fraction which stimulates the production of neutralizing antibody. J Virol (1972) 3.11
Glycoprotein D of herpes simplex virus (HSV) binds directly to HVEM, a member of the tumor necrosis factor receptor superfamily and a mediator of HSV entry. J Virol (1997) 3.05
Herpes simplex virus glycoprotein D can bind to poliovirus receptor-related protein 1 or herpesvirus entry mediator, two structurally unrelated mediators of virus entry. J Virol (1998) 3.00
Effect of tunicamycin on herpes simplex virus glycoproteins and infectious virus production. J Virol (1980) 2.99
Synthesis and processing of glycoproteins gD and gC of herpes simplex virus type 1. J Virol (1980) 2.94
Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene. Proc Natl Acad Sci U S A (1984) 2.85
In vitro studies of dental plaque formation: adsorption of oral streptococci to hydroxyaptite. Infect Immun (1979) 2.75
Localization of epitopes of herpes simplex virus type 1 glycoprotein D. J Virol (1985) 2.71
Purification of glycoprotein gD of herpes simplex virus types 1 and 2 by use of monoclonal antibody. J Virol (1982) 2.71
Structure of the HIV-1 integrase catalytic domain complexed with an inhibitor: a platform for antiviral drug design. Proc Natl Acad Sci U S A (1999) 2.69
Fine mapping of antigenic site II of herpes simplex virus glycoprotein D. J Virol (1989) 2.68
Comparative structural analysis of glycoprotein gD of herpes simplex virus types 1 and 2. J Virol (1980) 2.65
Structure of an antibody-antigen complex: crystal structure of the HyHEL-10 Fab-lysozyme complex. Proc Natl Acad Sci U S A (1989) 2.65
Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure. J Clin Invest (1991) 2.63
Effect of monoclonal antibodies on limited proteolysis of native glycoprotein gD of herpes simplex virus type 1. J Virol (1982) 2.62
Pathogenesis of influenza virus-induced pneumonia: involvement of both nitric oxide and oxygen radicals. Proc Natl Acad Sci U S A (1996) 2.46
Rabies group-specific ribonucleoprotein antigen and a test system for grouping and typing of rhabdoviruses. J Virol (1973) 2.40
In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases. Proc Natl Acad Sci U S A (1993) 2.40
Expression of herpes simplex virus type 1 glycoprotein D deletion mutants in mammalian cells. J Virol (1988) 2.29
Deoxyribonucleic acid synthesis in synchronized mammalian KB cells infected with herpes simplex virus. J Virol (1971) 2.25
Interaction of herpes simplex virus glycoprotein gC with mammalian cell surface molecules. J Virol (1995) 2.24
Ribonucleotide reductase activity of synchronized KB cells infected with herpes simplex virus. J Virol (1972) 2.23
Oligomeric structure of glycoproteins in herpes simplex virus type 1. J Virol (1996) 2.22
Interactions of vesicular stomatitis virus structural proteins with HeLa plasma membranes. Nat New Biol (1971) 2.19
Complement component C3b binds directly to purified glycoprotein C of herpes simplex virus types 1 and 2. Microb Pathog (1987) 2.15
Collaboration of antibody and inflammation in clearance of rabies virus from the central nervous system. J Virol (1998) 2.15
Rabies virus glycoprotein. II. Biological and serological characterization. Infect Immun (1977) 2.14
Monoclonal antibodies to distinct sites on herpes simplex virus (HSV) glycoprotein D block HSV binding to HVEM. J Virol (1998) 2.11
Structural analysis of precursor and product forms of type-common envelope glycoprotein D (CP-1 antigen) of herpes simplex virus type 1. J Virol (1979) 2.10
Purification and properties of bovine thymosin. Ann N Y Acad Sci (1975) 2.08
Structure-function analysis of soluble forms of herpes simplex virus glycoprotein D. J Virol (1996) 2.05
Pathogenicity of different rabies virus variants inversely correlates with apoptosis and rabies virus glycoprotein expression in infected primary neuron cultures. J Virol (1999) 2.04
The first immunoglobulin-like domain of HveC is sufficient to bind herpes simplex virus gD with full affinity, while the third domain is involved in oligomerization of HveC. J Virol (1999) 2.03
Induction and biological properties of defective interfering particles of rabies virus. J Virol (1977) 2.02
Examination of the kinetics of herpes simplex virus glycoprotein D binding to the herpesvirus entry mediator, using surface plasmon resonance. J Virol (1998) 2.02
Differences in cell-to-cell spread of pathogenic and apathogenic rabies virus in vivo and in vitro. J Virol (1985) 2.00
Localization of a binding site for herpes simplex virus glycoprotein D on herpesvirus entry mediator C by using antireceptor monoclonal antibodies. J Virol (2000) 1.98
High-level expression and purification of secreted forms of herpes simplex virus type 1 glycoprotein gD synthesized by baculovirus-infected insect cells. J Virol (1994) 1.97